As some of the most common chronic diseases globally, allergic diseases have been associated with the gut microbiome composition of both children and adults. The human milk microbiome has been proposed as a potential mediator in infant microbiome development; however, no studies have explored the human milk microbiome specifically in allergic women. This study aimed to investigate the determinants of the human milk microbiome in allergic women. Milk samples from the Infant Fish Oil Supplementation Study (IFOS; Australian Clinical Trials Registry ACTRN12606000281594) were collected at three (n = 229) and six (n = 171) months postpartum from women, who all had at least one allergic disease (e.g., asthma, allergic rhinitis). Full-length 16S rRNA gene sequencing was utilised to characterise the milk microbiome. Differences in alpha diversity and microbiome composition were assessed by linear mixed models, while beta diversity was assessed by PERMANOVA. The season of infant birth had the strongest relationship with the milk microbiome, with significant associations with beta diversity (p = 0.001) and 10 out of the 19 most abundant OTUs (>0.1% relative abundance). The milk microbiome composition was also significantly associated with the delivery mode, feeding status, parity, infant age, infant sex, maternal age, passive smoke exposure, and pets at home, aligning with previous findings from non-allergic women. Maternal allergy type was also significantly related to the composition of the milk microbiome. This study investigated the human milk microbiome in allergic mothers, revealing the season of infant birth as potentially the strongest influencer, along with associations between maternal, infant, and environmental factors. These findings suggest an interaction between season and maternal allergic diseases, which influences the microbiome.
Author Contributions
Conceptualization, D.T.G. and L.F.S.; methodology, L.F.S.; data collection D.J.P.; formal analysis, J.M.; investigation, J.M.; resources, D.T.G.; data curation, D.J.P.; writing—original draft preparation, J.M.; writing—review and editing, L.F.S., D.T.G. and D.J.P.; visualization, J.M.; supervision, L.F.S., D.T.G., D.J.P. and C.T.L.; project administration, L.F.S.; funding acquisition, D.T.G. All authors have read and agreed to the published version of the manuscript.
Funding
J.M., L.F.S., C.T.L., and D.T.G. are supported by an unrestricted research grant from Medela AG (Switzerland), administered by The University of Western Australia. J.M. was supported by an additional SIRF (Scholarships for International Research Fees) scholarship from The University of Western Australia and Ad Hoc Postgraduate Scholarship from Medela AG. D.J.P. is supported by a Telethon Kids Institute Ascend Fellowship. The funding bodies had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Institutional Review Board Statement
The study was conducted in accordance with the Declaration of Helsinki and was approved by the Princess Margaret Hospital Human Research Ethics Committee (HREC approval number 1111EP).
Informed Consent Statement
Written informed consent was obtained from all participants involved in the study.
Data Availability Statement
Data sharing not applicable.
Conflicts of Interest
D.T.G. declares participation in the Scientific Advisory Board of Medela AG. J.M., L.F.S., C.T.L. and D.T.G. are supported by an unrestricted research grant from Medela AG, administered by The University of Western Australia. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results. D.J.P. declares no conflict of interest.
| Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
, 